Kalderos will soon file an amended complaint in its case against HRSA before the U.S. District Court for the District of Columbia.

Kalderos to Resume Legal Battle Over HRSA’s Opposition to Drugmaker 340B Restrictions, Including Rebates

October 29, 2024 William Newton, Editor-in-Chief 340B Report Views

Kalderos, the drug industry vendor behind two 340B claims data submission platforms which support 340B rebates, will file an updated [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!